Lirimilast
Product Specifications
CAS Number
329306-27-6
Target
PDE
Related Pathways
Metabolism
Bioactivity
Lirimilast is an effective, selective, and orally active phosphodiesterase-4 (PDE4) inhibitor (IC50: 49 nM) . Lirimilast has potently anti-inflammatory properties. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease.
Smiles
CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(oc2c1)C(=O)c1ccc(Cl)cc1Cl
Molecular Formula
C17H12Cl2N2O6S
Molecular Weight
443.26
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1368735-01 0.02 mg (E-Coli)
Recombinant Caulobacter crescentus Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1)
Sign In for Pricing
View Details MBS1368735-02 0.1 mg (E-Coli)
Recombinant Caulobacter crescentus Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1)
Sign In for Pricing
View Details MBS1368735-03 0.02 mg (Yeast)
Recombinant Caulobacter crescentus Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1)
Sign In for Pricing
View Details MBS1368735-04 0.1 mg (Yeast)
Recombinant Caulobacter crescentus Lipoprotein-releasing system ATP-binding protein LolD 1 (lolD1)
Sign In for Pricing
View Details